These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3497258)

  • 1. Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.
    Gan BS; Hollenberg MD; MacCannell KL; Lederis K; Winkler ME; Derynck R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):331-7. PubMed ID: 3497258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct coronary artery receptor systems for epidermal growth factor-urogastrone.
    Gan BS; Hollenberg MD
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1277-82. PubMed ID: 2319470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.
    Gan BS; MacCannell KL; Hollenberg MD
    J Clin Invest; 1987 Jul; 80(1):199-206. PubMed ID: 3496362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
    Hollenberg MD; Muramatsu I; Itoh H; Patel P; Yang SG; Lederis K
    J Pharmacol Exp Ther; 1989 Jan; 248(1):384-90. PubMed ID: 2783610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular actions of epidermal growth factor-urogastrone: possible relationship to prostaglandin production.
    Muramatsu I; Hollenberg MD; Lederis K
    Can J Physiol Pharmacol; 1985 Aug; 63(8):994-9. PubMed ID: 3878226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: differential inhibition by indomethacin.
    Muramatsu I; Itoh H; Lederis K; Hollenberg MD
    J Pharmacol Exp Ther; 1988 May; 245(2):625-31. PubMed ID: 3259262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
    Yang SG; Ahmad S; Wong NC; Hollenberg MD
    Mol Pharmacol; 1994 Aug; 46(2):256-65. PubMed ID: 8078489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor-urogastrone (EGF-URO) causes contraction of porcine coronary arterial strips: inhibition by indomethacin.
    Gan BS; Hollenberg MD; Lederis K
    Proc West Pharmacol Soc; 1989; 32():269-71. PubMed ID: 2789386
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic actions of epidermal growth factor-urogastrone and vasopressin in cultured aortic A-10 smooth muscle cells.
    Mokashi S; Severson DL; Hollenberg MD
    J Cell Physiol; 1992 Aug; 152(2):372-81. PubMed ID: 1386368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the C-terminal dipeptide of transforming growth factor-alpha to its activity: biochemical and pharmacologic profiles.
    Yang SG; Winkler ME; Hollenberg MD
    Eur J Pharmacol; 1990 Jun; 188(6):289-300. PubMed ID: 2115447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
    Korc M; Haussler CA; Trookman NS
    Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by epidermal growth factor--urogastrone of contraction in isolated canine helical mesenteric arterial strips.
    Muramatsu I; Hollenberg MD; Lederis K
    Can J Physiol Pharmacol; 1986 Dec; 64(12):1561-5. PubMed ID: 3493833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractile action of ethanol in guinea pig gastric smooth muscle: inhibition by tyrosine kinase inhibitors and comparison with the contractile action of epidermal growth factor-urogastrone.
    Zheng XL; Mokashi S; Hollenberg MD
    J Pharmacol Exp Ther; 1997 Jul; 282(1):485-95. PubMed ID: 9223591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol lipase and the contractile action of epidermal growth factor-urogastrone: evidence for distinct signal pathways in a single strip of gastric smooth muscle.
    Yang SG; Saifeddine M; Chuang M; Severson DL; Hollenberg MD
    Eur J Pharmacol; 1991 Jul; 207(3):225-30. PubMed ID: 1909965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
    Wang L; Lucey MR; Fras AM; Wilson EJ; Del Valle J
    J Pharmacol Exp Ther; 1993 Apr; 265(1):308-13. PubMed ID: 8474014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle.
    Yang SG; Saifeddine M; Hollenberg MD
    Can J Physiol Pharmacol; 1992 Jan; 70(1):85-93. PubMed ID: 1316219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome.
    Koski H; Konttinen YT; Hietanen J; Tervo T; Malmström M
    J Rheumatol; 1997 Oct; 24(10):1930-5. PubMed ID: 9330934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3'-kinase.
    Zheng XL; Renaux B; Hollenberg MD
    J Pharmacol Exp Ther; 1998 Apr; 285(1):325-34. PubMed ID: 9536028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by anti-inflammatory agents of contraction induced by epidermal growth factor-urogastrone in isolated longitudinal smooth muscle strips from guinea-pig stomach.
    Itoh H; Muramatsu I; Patel P; Lederis K; Hollenberg MD
    Br J Pharmacol; 1988 Nov; 95(3):821-9. PubMed ID: 3264733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
    Reddy CC; Wells A; Lauffenburger DA
    J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.